Welcome fellow BRN holder!
Yep, this cap raise was flagged well in advance, and at some 28.3c, for the initial placement per share, is on better terms than I had expected (ie: they're paying an ~18 premium to the current price). And in response to a premium paid, the ASX drops the price. Lol. I can definitely see why FGR is targetting US funds and US investors, at this point.
That range on figures on the additional 3M shares, is also interesting, ie:
The placement will be made by way of the Investor prepaying a lump sum of
$5,000,000 for $5,300,000 worth of the Company’s ordinary shares (Placement
Shares). Additionally, the Company will have the option (but no obligation) to
require the Investor to subscribe for an additional $3,180,000 worth of Placement
Shares on payment of $3,000,000 in subscription proceeds. The Company may
exercise this option at any time prior to 1 September 2021, and if the Company
exercises this option, the Investor will be required to pay the subscription proceeds
no later than 30 November 2021. The Company will issue the Placement Shares in
relation to all or part of each of the above investments on the Investor’s request,
during the period ending 24 months after the date of the investment. The number
of shares so issued by the Company will be determined by applying the Purchase
Price (as set out below) to the subscription amount. The Purchase Price will initially
be equal to $0.30 per share and will reset after 10 August 2021 to the average of
the five daily volume-weighted average prices selected by the Investor during the
20 consecutive trading days immediately prior to the date of the Investor’s notice
to issue shares, rounded down to the next half a cent if the share price is at below
50 cents and whole cent if the share price is at above 50 cents, with no discount
applicable to this formula. To the extent that Placement Shares are issued after
six months, or 12 months, the Investor will receive a discount of, respectively, 3%
or 6% to the foregoing Purchase Price formula.
The Purchase Price will be the subject of a Floor Price of $0.16. If the Purchase
Price formula were to result in a purchase price that is less than the Floor Price,
the Company may refuse to issue shares and instead opt to repay the relevant
subscription amount in cash (with a 5% premium), subject to the Investor’s right
to receive Placement Shares at the Floor Price in lieu of such cash repayment. The
Purchase Price will not be the subject of a cap.
- Forums
- ASX - By Stock
- FGR
- Ann: Institutional Placement to Underwrite Growth Strategy
Ann: Institutional Placement to Underwrite Growth Strategy, page-12
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FGR (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
-0.003(8.11%) |
Mkt cap ! $22.77M |
Open | High | Low | Value | Volume |
3.7¢ | 3.7¢ | 3.2¢ | $6.804K | 197.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31723 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 110500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31723 | 0.032 |
6 | 564675 | 0.030 |
1 | 25000 | 0.025 |
1 | 22394 | 0.023 |
1 | 118000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 110500 | 1 |
0.040 | 275284 | 2 |
0.043 | 122904 | 2 |
0.045 | 100000 | 1 |
0.047 | 239393 | 3 |
Last trade - 15.34pm 12/11/2024 (20 minute delay) ? |
Featured News
FGR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online